Skip to main content
Erschienen in:

11.09.2024 | Other Articles

Does Changes in the Muscles Beneath the Submucosal Tissues Necessitate a Novel Strategy in the Medical Management of OSMF: A Systematic Review

verfasst von: Uday Kiran Uppada

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 6/2024

Einloggen, um Zugang zu erhalten

Abstract

This study is envisioned to assess the structural changes the muscles undergo beneath the submucosal tissues and whether these changes necessitate a novel strategy from the existing conventional modality in the treatment of oral submucous fibrosis (OSMF) medically through a systematic literature survey. Literature search was performed electronically using Medline, EMBASE and CENTRAL databases to identify published literature until the end of April 2024 in dental, oral and maxillofacial surgery, plastic surgery and otolaryngology journals containing the terms “oral submucous fibrosis”, “muscles of mastication”, “muscles of facial expression”, “histopathologic study”, “ultrasonographic study”, “CT”, “MRI” in either their titles, abstracts, and keywords with only English being the preferred language. The data was extracted from the selected articles and prudently studied to gather and compile the data. Descriptive data from all the carefully chosen articles were selected and analysed. Seven studies met the inclusion criteria. It was observed that the masseter muscle was the first to be involved in the disease process of OSMF among the muscles of mastication and facial expression. It was observed that the anterior temporalis and orbicularis oris muscles remained unaffected. However, the buccinator muscle which lies in utmost vicinity is not evaluated in the included studies. The degree of muscle degeneration and the degree of disease progression were directly related to the duration of the habit. The restricted mouth opening noticed in OSMF is not only governed by the subepithelial fibrosis but also on the extent of muscle degeneration. The changes the surrounding muscles undergo could be a manifestation of the disease, atrophy as a sequalae to the limited functional activity of the muscles which is brought about by fibrosis or it could be an essential part of the disease itself.
Literatur
1.
Zurück zum Zitat Binnie WH, Cawson RA (1972) A new ultrastructural finding in oral submucous fibrosis. Br J Dermatol 86:286–289CrossRefPubMed Binnie WH, Cawson RA (1972) A new ultrastructural finding in oral submucous fibrosis. Br J Dermatol 86:286–289CrossRefPubMed
2.
Zurück zum Zitat El-Labban NG, Caniff JP (1985) Ultrastructural findings of muscle degeneration in oral submucous fibrosis. J Oral Pathol 14:709–717CrossRefPubMed El-Labban NG, Caniff JP (1985) Ultrastructural findings of muscle degeneration in oral submucous fibrosis. J Oral Pathol 14:709–717CrossRefPubMed
3.
Zurück zum Zitat Khanna JN, Andrade NN (1995) Oral submucous fibrosis: a concept in surgical management. Int J Oral Maxillofac Surg 24:433–439CrossRefPubMed Khanna JN, Andrade NN (1995) Oral submucous fibrosis: a concept in surgical management. Int J Oral Maxillofac Surg 24:433–439CrossRefPubMed
4.
Zurück zum Zitat Kant P, Bhowate RR, Sharda N (2014) Assessment of cross-sectional thickness and activity of masseter, anterior temporalis and orbicularis oris muscles in oral submucous fibrosis patients and healthy controls: an ultrasonography and electromyography study. Dentomaxillofac Radiol 43:20130016CrossRefPubMedPubMedCentral Kant P, Bhowate RR, Sharda N (2014) Assessment of cross-sectional thickness and activity of masseter, anterior temporalis and orbicularis oris muscles in oral submucous fibrosis patients and healthy controls: an ultrasonography and electromyography study. Dentomaxillofac Radiol 43:20130016CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Emshoff R, Bertram S, Brandlmaier I (2002) Ultrasonographic assessment of local cross-sectional dimensions of masseter muscle sites: a reproducible technique. J Oral Rehabil 29:1059–1062CrossRefPubMed Emshoff R, Bertram S, Brandlmaier I (2002) Ultrasonographic assessment of local cross-sectional dimensions of masseter muscle sites: a reproducible technique. J Oral Rehabil 29:1059–1062CrossRefPubMed
6.
Zurück zum Zitat Misra UK, Kalita J (2001) Clinical neurophysiology. Nerve conduction, electromyography, evoked potentials. B.I. Churchill Livingstone, New Delhi, India, pp 114–126 Misra UK, Kalita J (2001) Clinical neurophysiology. Nerve conduction, electromyography, evoked potentials. B.I. Churchill Livingstone, New Delhi, India, pp 114–126
7.
Zurück zum Zitat Tamgadge S, Tamgadge A (2020) Histopathology of oral submucous fibrosis in third dimension with an additional note on hypothesis of epithelial atrophy. J Microsc Ultrastruct 8:31–34CrossRefPubMed Tamgadge S, Tamgadge A (2020) Histopathology of oral submucous fibrosis in third dimension with an additional note on hypothesis of epithelial atrophy. J Microsc Ultrastruct 8:31–34CrossRefPubMed
8.
Zurück zum Zitat Meyer M, Müller AK, Yang J, Ŝulcová J, Werner S (2011) The role of chronic inflammation in cutaneous fibrosis: fibroblast growth factor receptor deficiency in keratinocytes as an example. J Investig Dermatol Symp Proc 15:48–52CrossRefPubMed Meyer M, Müller AK, Yang J, Ŝulcová J, Werner S (2011) The role of chronic inflammation in cutaneous fibrosis: fibroblast growth factor receptor deficiency in keratinocytes as an example. J Investig Dermatol Symp Proc 15:48–52CrossRefPubMed
9.
Zurück zum Zitat Ekanayaka RP, Tilakaratne WM (2013) Oral submucous fibrosis: review on mechanisms of pathogenesis and malignant transformation. J Carcinog Mutagen S5:002 Ekanayaka RP, Tilakaratne WM (2013) Oral submucous fibrosis: review on mechanisms of pathogenesis and malignant transformation. J Carcinog Mutagen S5:002
10.
Zurück zum Zitat Isaac U, Issac JS, Ahmed Khoso N (2008) Histopathologic features of oral submucous fibrosis: a study of 35 biopsy specimens. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:556–560CrossRefPubMed Isaac U, Issac JS, Ahmed Khoso N (2008) Histopathologic features of oral submucous fibrosis: a study of 35 biopsy specimens. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:556–560CrossRefPubMed
11.
Zurück zum Zitat Chawla H, Urs Ab, Augustine J, Kumar P (2015) Characterization of muscle alteration in oral submucous fibrosis-seeking new evidence. Med Oral Patol Oral Cir Bucal 20(6):e670–e677CrossRefPubMedPubMedCentral Chawla H, Urs Ab, Augustine J, Kumar P (2015) Characterization of muscle alteration in oral submucous fibrosis-seeking new evidence. Med Oral Patol Oral Cir Bucal 20(6):e670–e677CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Sumathi M, Balaji N, Malathi N (2012) A prospective transmission electron microscopic study of muscle status in oral submucous fibrosis along with retrospective analysis of 80 cases of oral submucous fibrosis. J Oral Maxillofac Pathol 16:318–324CrossRefPubMedPubMedCentral Sumathi M, Balaji N, Malathi N (2012) A prospective transmission electron microscopic study of muscle status in oral submucous fibrosis along with retrospective analysis of 80 cases of oral submucous fibrosis. J Oral Maxillofac Pathol 16:318–324CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Smitha BR, Donoghue M (2011) Clinical and histopathological evaluation of collagen fiber orientation in patients with oral submucous fibrosis. J Oral Maxillofac Pathol 15:154–160CrossRefPubMedPubMedCentral Smitha BR, Donoghue M (2011) Clinical and histopathological evaluation of collagen fiber orientation in patients with oral submucous fibrosis. J Oral Maxillofac Pathol 15:154–160CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Naik C, Panda BK, Avijeeta A, Pattnaik B, Dany SS, Panda S et al (2020) Assessment of masseter muscle thickness in OSMF patients - a computed tomography study. J Evid Based Med Healthc 7(52):3176–3179CrossRef Naik C, Panda BK, Avijeeta A, Pattnaik B, Dany SS, Panda S et al (2020) Assessment of masseter muscle thickness in OSMF patients - a computed tomography study. J Evid Based Med Healthc 7(52):3176–3179CrossRef
15.
16.
Zurück zum Zitat Gray HW (2005) In: Grays A, Standring S (eds) Cells and tissues, 39th edn. Churchill Livingstone, Edinburgh, pp 36–40 Gray HW (2005) In: Grays A, Standring S (eds) Cells and tissues, 39th edn. Churchill Livingstone, Edinburgh, pp 36–40
17.
Zurück zum Zitat Rooban T, Saraswathi TR, Zainab FHA, Devi U, Eligabeth J, Ranganathan K et al (2005) A light microscopic study of fibrosis involving muscle in oral submucous fibrosis. Indian J Dent Res 16(4):131–134CrossRefPubMed Rooban T, Saraswathi TR, Zainab FHA, Devi U, Eligabeth J, Ranganathan K et al (2005) A light microscopic study of fibrosis involving muscle in oral submucous fibrosis. Indian J Dent Res 16(4):131–134CrossRefPubMed
18.
Zurück zum Zitat Adhane YB, Sachdev SS, Sardar MA, Chettiankandy TJ, Sonawane SG (2021) Oral submucous fibrosis: histopathological features with pathophysiologic correlations. IP J Diagn Pathol Oncol 6(3):211–215CrossRef Adhane YB, Sachdev SS, Sardar MA, Chettiankandy TJ, Sonawane SG (2021) Oral submucous fibrosis: histopathological features with pathophysiologic correlations. IP J Diagn Pathol Oncol 6(3):211–215CrossRef
19.
Zurück zum Zitat More CB, Gavli N, Chen Y, Rao NR (2018) A novel clinical protocol for therapeutic intervention in oral submucous fibrosis: an evidence-based approach. J Oral Maxillofac Pathol 22(3):382–391CrossRefPubMedPubMedCentral More CB, Gavli N, Chen Y, Rao NR (2018) A novel clinical protocol for therapeutic intervention in oral submucous fibrosis: an evidence-based approach. J Oral Maxillofac Pathol 22(3):382–391CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Singh P, Pandey A, Shingh A, Ahuja T, Sharma S, Bhagalia S, Trehan M (2016) Efficacy of intralesional placental extract, dexamethasone and hyaluronidase in treatment of oral submucous fibrosis: a comparative study. JK Pract 21(1–2):29–34 Singh P, Pandey A, Shingh A, Ahuja T, Sharma S, Bhagalia S, Trehan M (2016) Efficacy of intralesional placental extract, dexamethasone and hyaluronidase in treatment of oral submucous fibrosis: a comparative study. JK Pract 21(1–2):29–34
21.
Zurück zum Zitat Warnakulasuriya S, Kerr AR (2016) Oral submucous fibrosis: a review of the current management and possible directions for novel therapies. Oral Surg Oral Med Oral Pathol Oral Radiol 122(2):232–241CrossRefPubMed Warnakulasuriya S, Kerr AR (2016) Oral submucous fibrosis: a review of the current management and possible directions for novel therapies. Oral Surg Oral Med Oral Pathol Oral Radiol 122(2):232–241CrossRefPubMed
22.
Zurück zum Zitat Arakeri G, Rai KK, Boraks G et al (2017) Current protocols in the management of oral submucous fibrosis: an update. J Oral Pathol Med 46(6):418–423CrossRefPubMed Arakeri G, Rai KK, Boraks G et al (2017) Current protocols in the management of oral submucous fibrosis: an update. J Oral Pathol Med 46(6):418–423CrossRefPubMed
23.
Zurück zum Zitat Chole RH, Gondivkar SM, Gadbail AR et al (2012) Review of drug treatment of oral submucous fibrosis. Oral Oncol 48(5):393–398CrossRefPubMed Chole RH, Gondivkar SM, Gadbail AR et al (2012) Review of drug treatment of oral submucous fibrosis. Oral Oncol 48(5):393–398CrossRefPubMed
24.
Zurück zum Zitat Zhang Z, Shang J, Yang Q, Dai Z, Liang Y, Lai C, Feng T, Zhong D, Zou H, Sun L, Su Y, Yan S, Chen J, Yao Y, Shi Y, Huang X (2023) Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism. J Nanobiotechnol 25(1):29CrossRef Zhang Z, Shang J, Yang Q, Dai Z, Liang Y, Lai C, Feng T, Zhong D, Zou H, Sun L, Su Y, Yan S, Chen J, Yao Y, Shi Y, Huang X (2023) Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism. J Nanobiotechnol 25(1):29CrossRef
25.
Zurück zum Zitat Wang B, Yao K, Huuskes BM, Shen HH, Zhuang J, Godson C et al (2016) Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis. Mol Ther 24(7):1290–1301CrossRefPubMedPubMedCentral Wang B, Yao K, Huuskes BM, Shen HH, Zhuang J, Godson C et al (2016) Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis. Mol Ther 24(7):1290–1301CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Setayesh K, Villarreal A, Gottschalk A, Tokish JM, Choate WS (2018) Treatment of Muscle Injuries with platelet-rich plasma: a review of the literature. Curr Rev Musculoskelet Med 11(4):635–642CrossRefPubMedPubMedCentral Setayesh K, Villarreal A, Gottschalk A, Tokish JM, Choate WS (2018) Treatment of Muscle Injuries with platelet-rich plasma: a review of the literature. Curr Rev Musculoskelet Med 11(4):635–642CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Naag S, Savirmath A, Kalakonda BB, Uppada UK, Kamisetty S, Priyadarshini E (2015) Platelet concentrates: Bioengineering dentistry’s regenerative dreams. J Dent Res Rev 2(2):86–90CrossRef Naag S, Savirmath A, Kalakonda BB, Uppada UK, Kamisetty S, Priyadarshini E (2015) Platelet concentrates: Bioengineering dentistry’s regenerative dreams. J Dent Res Rev 2(2):86–90CrossRef
28.
Zurück zum Zitat Kunze KN, Hannon CP, Fialkoff JD, Frank RM, Cole BJ (2019) Platelet-rich plasma for muscle injuries: a systematic review of the basic science literature. World J Orthop 18(7):278–291CrossRef Kunze KN, Hannon CP, Fialkoff JD, Frank RM, Cole BJ (2019) Platelet-rich plasma for muscle injuries: a systematic review of the basic science literature. World J Orthop 18(7):278–291CrossRef
Metadaten
Titel
Does Changes in the Muscles Beneath the Submucosal Tissues Necessitate a Novel Strategy in the Medical Management of OSMF: A Systematic Review
verfasst von
Uday Kiran Uppada
Publikationsdatum
11.09.2024
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 6/2024
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-024-05063-2

Neu im Fachgebiet HNO

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Kopf-Hals-Tumore: Lebensqualität von Langzeitüberlebenden

Eine aktuelle Studie des Universitätsklinikums Erlangen verdeutlicht, dass Langzeitüberlebende von Kopf-Hals-Tumoren eine geringe Symptomlast aufweisen. Die am häufigsten auftretenden Beschwerden – Müdigkeit, Angstzustände, Schläfrigkeit und Schmerzen – sollten von den behandelnden Ärztinnen und Ärzten gezielt adressiert werden.

Schlafapnoe – es lag an einer verbogenen Nasenscheidewand

Tritt eine obstruktive Schlafapnoe vor allem in einer bestimmten Seitenlage auf, kann dies auch an einem verbogenen Nasenseptum liegen. Eine Septumplastik lindert die Beschwerden mitunter deutlich.

Das alles ändert sich für Arztpraxen in 2025

  • 31.12.2024
  • EBM
  • Nachrichten

Ab Januar greifen jede Menge Neuerungen – ob im EBM, Arbeits- und Steuerrecht oder bei der digitalen Vernetzung. Darunter einige Verbesserungen, aber teils auch Mehraufwand. „Same procedure as every year?“ – Ein Überblick.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.